Alliancebernstein L.P. Atri Cure, Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,573,649 shares of ATRC stock, worth $124 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,573,649
Previous 3,676,849
2.81%
Holding current value
$124 Million
Previous $119 Million
1.27%
% of portfolio
0.04%
Previous 0.05%
Shares
26 transactions
Others Institutions Holding ATRC
# of Institutions
221Shares Held
51.8MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.91MShares$170 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$160 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$138 Million0.02% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$106 Million1.62% of portfolio
-
Macquarie Group LTD Australia, C32.5MShares$86.9 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.61B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...